PATENT CLAIM ANALYSIS

Application Number: 16432071
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["424", "094640"]

Abstract:
The present invention provides methods for preventing and/or treating bleeding episodes by administering a single dose of a Factor VIIa equivalent. Preferably, the single dose comprises between about 150 and about 500 ug/kg Factor VIIa equivalent.

Claim (Index 6):
A method as defined in  claim 1 , wherein said Factor VIIa equivalent is selected from the group consisting of: S52A-FVII, S60A-FVII; L305V-FVII, L305V/M306D/D309S-FVII, L305I-FVII, L305T-FVII, F374P-FVII, V158T/M298Q-FVII, V158D/E296V/M298Q-FVII, K337A-FVII, M298Q-FVII, V158D/M298Q-FVII, L305V/K337A-FVII, V158D/E296V/M298Q/L305V-FVII, V158D/E296V/M298Q/K337A-FVII, V158D/E296V/M298Q/L305V/K337A-FVII, K157A-FVII, E296V-FVII, E296V/M298Q-FVII, V158D/E296V-FVII, V158D/M298K-FVII, and S336G-FVII; Factor VIIa that has been proteolytically cleaved between residues 290 and 291; Factor VIIa that has been proteolytically cleaved between residues 315 and 316; and oxidized forms of Factor VIIa.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 100.0
- Lexical Diversity: 1.25806
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12127917', '16214996', '10290814', '13987492', '15258908']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.785234913069342
- 35 USC 102 Novelty (BERT): 0.6567507638059747
- Combined Prediction Score: 0.7723864981430053
- Mean Citation Score: 488.54998600000016
- Max Citation Score: 646.3531
- Similarity Product: 618.6244197283388

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test